Cost Is an Adherence Barrier — Here's How Providers Can Help

You've diagnosed the psoriasis, confirmed the acne isn't responding to first-line therapy, or decided a potent retinoid is warranted for photoaging. You write the Tazarotene prescription. Two weeks later, the patient hasn't filled it — or they filled it once and won't refill.

The reason, more often than not, is cost.

Brand-name Tazorac can run $250–$600 per tube. Even generic Tazarotene, at $40–$150, can be a stretch for patients without robust prescription coverage. And in dermatology, where topical medications are often used long-term and aren't always seen as "essential" by payers, cost-related non-adherence is especially common.

This guide outlines the concrete savings programs and strategies you can incorporate into your prescribing workflow to keep patients on Tazarotene when it's the right medication for them.

What Patients Are Actually Paying

Understanding the cost landscape helps you anticipate where patients will hit barriers:

• Brand-name Tazorac (cream/gel): $250–$600 retail for a 30-60g tube
• Brand-name Fabior (foam): $400–$700 retail
• Generic Tazarotene (cream/gel): $40–$150 retail for a 30-45g tube
• With insurance (generic, preferred): $10–$50 copay typical
• With insurance (brand, non-preferred): $75–$200+ copay, often after prior authorization

Key cost drivers to be aware of:

• Prior authorization is commonly required, even for generic. This delays fill times and can result in patients giving up.
• Step therapy requirements — Some plans require documentation that Adapalene or Tretinoin was tried first.
• Quantity limits — Payers may limit tube size or number per fill, especially for brand.
• Medicare Part D coverage varies widely by plan, and there's no manufacturer copay card option for Medicare patients.

Manufacturer Savings Programs

Allergan/AbbVie — Tazorac

Allergan has historically offered copay savings cards for Tazorac that can reduce out-of-pocket costs to $0–$35 per month for commercially insured patients. These programs typically:

• Cover the difference between the patient's copay and $0–$35
• Have annual maximum benefit caps (e.g., $3,000–$6,000/year)
• Are not available for Medicare, Medicaid, or other government-funded insurance
• Require enrollment on the manufacturer's website or through your office

Check the Allergan/AbbVie website for current program availability and enrollment details. These programs change periodically.

Stiefel/GSK — Fabior

Fabior has also had manufacturer coupon programs. Given its higher retail price ($400–$700), these savings cards are especially important for patients prescribed the foam formulation. Verify current status at the manufacturer site.

Patient Assistance Programs (PAPs)

For uninsured or underinsured patients, the AbbVie/Allergan Patient Assistance Foundation may provide Tazorac at no cost. Eligibility is typically based on:

• Household income (often below 200-400% of federal poverty level)
• Lack of prescription drug coverage or coverage that doesn't cover the medication
• U.S. residency

Application requires a prescription from the provider and documentation of financial need. Processing typically takes 2-4 weeks. Additional resources:

• NeedyMeds (needymeds.org) — Comprehensive database of PAPs
• RxAssist (rxassist.org) — Patient assistance program directory
• RxHope (rxhope.com) — Application assistance for manufacturer programs

Coupon and Discount Cards

For patients paying out of pocket or facing high copays on generic Tazarotene, third-party discount cards can provide significant savings:

• GoodRx — Shows prices at nearby pharmacies with free coupons. Generic Tazarotene prices through GoodRx can be 40-70% below retail at some pharmacies.
• SingleCare — Similar pharmacy discount program with competitive pricing.
• RxSaver, Optum Perks, BuzzRx — Additional coupon platforms patients can compare.
• Walgreens Rx Savings, Inside Rx, America's Pharmacy — Pharmacy-specific or specialty discount programs.

Key points for providers:

• Coupon cards work for generic Tazarotene at most retail pharmacies
• They cannot be combined with insurance — patients use one or the other per fill
• Prices vary by pharmacy, so encourage patients to compare
• These cards are free — patients should be wary of any service that charges a fee

Having a printed list of these resources (or a link to this savings guide for patients) can be a simple but effective addition to your patient handout materials.

Generic Alternatives and Therapeutic Substitution

Always Prescribe Generic When Possible

Generic Tazarotene is bioequivalent to Tazorac and available at a fraction of the cost. Unless there's a documented formulation-specific reason (rare), prescribe generic by default. Write "Tazarotene" rather than "Tazorac" on the prescription, and ensure the "dispense as written" (DAW) box is not checked.

Consider Therapeutic Alternatives When Cost Is Prohibitive

If even generic Tazarotene is out of reach, consider whether a therapeutic alternative would serve the patient:

• Adapalene (Differin) 0.1% — Available over the counter for about $10–$15. Less potent but well-tolerated. Appropriate for mild to moderate acne.
• Adapalene 0.3% (Rx) — Generic available, typically $20–$60. Stronger than OTC but still less irritating than Tazarotene.
• Tretinoin (generic) — $20–$80 for generic cream or gel. Broad retinoid with decades of clinical data. Good for acne and photoaging (not FDA-approved for psoriasis).
• Trifarotene (Aklief) — Newer, brand-only, so cost may be comparable or higher. But manufacturer savings programs may make it competitive.
• Calcipotriene (Dovonex, generic) — For psoriasis patients, a vitamin D analog alternative when retinoid cost is the barrier.

Document the therapeutic rationale for any substitution to support future prior authorization attempts for Tazarotene if the patient's condition warrants returning to it.

Building Cost Conversations into Your Workflow

The most effective time to address cost is before the patient leaves your office, not after they get sticker shock at the pharmacy. Here are practical steps:

At the Point of Prescribing

• Ask about coverage — "What kind of prescription drug coverage do you have?" A 30-second question can prevent a wasted prescription.
• Check formulary status — Use your EHR's formulary lookup or tools like CoverMyMeds to verify coverage and PA requirements in real time.
• Set expectations — "Generic Tazarotene typically costs $40–$150 without insurance. Let me make sure we find the best price for you."

Proactive Prior Authorization

• Submit PAs before the patient goes to the pharmacy. Services like CoverMyMeds and SureScripts ePA can streamline this.
• Include clinical documentation: diagnosis, previous treatments tried, and medical necessity.
• For step therapy requirements, document prior use of Tretinoin or Adapalene in the PA submission.

Patient Education Materials

• Provide a one-page handout with savings resources (coupon card websites, PAP phone numbers)
• Direct patients to comprehensive savings guides
• If patients have trouble finding Tazarotene in stock, suggest Medfinder for providers to help identify pharmacy availability

Follow-Up on Adherence

• At follow-up visits, ask specifically: "Have you been able to fill and use the Tazarotene?"
• If cost was a barrier, revisit the alternatives and assistance programs above
• Track PA expiration dates — many are valid for only 6-12 months and need renewal

Quick Reference: Cost Resources for Tazarotene

• Manufacturer savings (Tazorac): Allergan/AbbVie copay card — $0–$35/month for commercial insurance
• Patient assistance: AbbVie Patient Assistance Foundation — free medication for qualifying patients
• Coupon cards: GoodRx, SingleCare, RxSaver, Optum Perks
• Generic price range: $40–$150 retail, potentially lower with coupons
• OTC alternative: Adapalene (Differin) 0.1% — ~$10–$15
• Patient guide: Medfinder Tazarotene Savings Guide
• Provider tools: Medfinder for Providers

Final Thoughts

Tazarotene is an effective medication for psoriasis, acne, and photoaging — but its value depends entirely on whether patients can actually afford to use it consistently. By prescribing generic first, proactively addressing insurance barriers, and connecting patients with savings programs, you can significantly improve adherence and outcomes.

The cost conversation isn't separate from the clinical conversation. It is the clinical conversation. Because a medication the patient can't afford is a medication that doesn't work.

For additional provider resources on medication access and availability, visit Medfinder for Providers.